Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 164 recruiting now full pipeline #13 of 28,963 conditions

Heart Failure: full-pipeline trial registry

164 of 399 indexed Heart Failure trials are currently recruiting.

Corpus placement: #13 of 28,963 conditions by registered trial count.

399 US clinical trials · 164 currently recruiting · #13 of 28,963 conditions by registered trial count

Heart Failure: 399 US clinical trials tracked, 164 recruiting.

Heart Failure is the subject of 399 registered US clinical trials on ClinicalTrials.gov, 164 of them currently open to new participants. 47 are in Phase 3-4 (later-stage) and 63 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 15 of these trials.

Open enrollment snapshot

Heart Failure has 399 registered US clinical trials, 164 of them open to new participants right now, about 41% of the total.

164
recruiting participants now
41%
of trials open to enrollment
47
in Phase 3-4 (later-stage)
15
top sponsor: Abbott Medical Devices

Corpus placement: #13 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Heart Failure on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Heart Failure is recruiting above its size-band peers.

    164 of 399 indexed trials (41.1%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Heart Failure trials is spread across many organizations.

    Abbott Medical Devices accounts for 15 of 399 trials (3.8%). 195 distinct sponsors appear on at least one study for this condition label.

  3. Typical Heart Failure enrolment sits around 128 participants.

    Median target enrolment is 128 among the 398 trials that report a genuine target (sentinel values excluded). 177 of those (44.5%) plan for fewer than 100 participants.

  4. Heart Failure research is mostly interventional.

    297 interventional and 102 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 128Phase 235Phase 324Phase 423

Open and recent trials

399 total, page 7 of 8

COMPLETED NA 105 participants

Self-management Adherence in Heart Failure Patients

University of Nebraska

NCT01964053

COMPLETED NA 105 participants

Leveraging Home Health Aides to Improve Outcomes in Heart Failure

Weill Medical College of Cornell University

NCT04239911

COMPLETED Phase 3 100 participants

Tai Chi Mind-Body Therapy for Chronic Heart Failure

Beth Israel Deaconess Medical Center

NCT00110227

COMPLETED 85 participants

Creation of a Digital Heart Failure Registry Using a Novel Mobile Health Platform: HUGO-HF

Yale University

NCT03810638

COMPLETED NA 76 participants

Animal-Assisted Therapy for Hospitalized Heart Failure Patients

University of California, Los Angeles

NCT00391456

COMPLETED NA 75 participants

Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study

Abbott Medical Devices

NCT00500838

COMPLETED 75 participants

Identifying Diuretic Resistance in Patients With Acute Heart Failure

Vanderbilt University

NCT02751242

COMPLETED Phase 4 74 participants

Oxygen Versus PAP for Sleep Apnea in Heart Failure

VA Office of Research and Development

NCT01807897

COMPLETED 73 participants

Model 4965 Post-Approval Study

Medtronic

NCT01076348

COMPLETED Phase 1 72 participants

Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules

Pfizer

NCT04967443

COMPLETED 72 participants

Establishing a Non-invasive Method to Measure Your Heart's Performance

Marie Csete MD, PhD

NCT02240979

COMPLETED NA 71 participants

Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study

Duke University

NCT03775759

COMPLETED NA 71 participants

Dietary Prevention of Heart Failure in Hypertensive Metabolic Syndrome

VA Office of Research and Development

NCT03170375

COMPLETED NA 70 participants

Disease Management Platform for Heart Failure (DMP-HF)

Massachusetts General Hospital

NCT04782973

COMPLETED NA 69 participants

Exercise and Cognitive Retraining to Improve Cognition in Heart Failure.

Emory University

NCT02151266

COMPLETED Phase 1 68 participants

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Abramson Cancer Center at Penn Medicine

NCT04023110

COMPLETED 62 participants

BVA-200 vs BVA-100 Validation Study

Daxor Corporation

NCT06227819

COMPLETED 60 participants

Monocyte Phenotypic Changes in Heart Failure

University of Michigan

NCT02997462

COMPLETED NA 60 participants

Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation

University of California, San Diego

NCT02111993

COMPLETED NA 60 participants

Strategies for Aggressive Central Afterload Reduction in Patients With Heart Failure

Mayo Clinic

NCT00588692

COMPLETED Phase 4 60 participants

Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure

Vanderbilt University

NCT02606253

COMPLETED NA 60 participants

Study of Reminding to Improve Medication Adherence in Heart Failure

Kent State University

NCT01463267

COMPLETED Phase 2 60 participants

Interleukin-1 Blockade in Recently Decompensated Heart Failure

Virginia Commonwealth University

NCT01936909

COMPLETED Phase 1 58 participants

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

Nile Therapeutics

NCT01316432

COMPLETED NA 57 participants

Teach-Back Discharge Education to Improve Self-Care and Reduce 30-Day Readmissions in Heart Failure Patients

Nova Southeastern University

NCT07280208

COMPLETED Phase 2 56 participants

Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

Thomas Jefferson University

NCT03243942

COMPLETED 56 participants

Frailty in Children With Cardiac Disease

Children's Mercy Hospital Kansas City

NCT02999438

COMPLETED Phase 4 55 participants

Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure

Michael E. DeBakey VA Medical Center

NCT01261065

COMPLETED NA 54 participants

The Cascade Feasibility Pilot (HF) Phase 3

Endeavor Health

NCT04993287

COMPLETED 53 participants

Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children

University of Colorado, Denver

NCT02728128

COMPLETED 52 participants

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.

Tricog Health

NCT05906745

COMPLETED NA 50 participants

Focused Palliative Care Intervention in Advanced Heart Failure

Brigham and Women's Hospital

NCT02805712

COMPLETED NA 50 participants

RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators

University of California, San Diego

NCT02111980

COMPLETED Phase 2 49 participants

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

Bristol-Myers Squibb

NCT03357731

COMPLETED 48 participants

Body Composition Ultrasound for Patients With Heart Failure

Tufts Medical Center

NCT03948776

COMPLETED Phase 3 47 participants

Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure

Yale University

NCT05093621

COMPLETED NA 47 participants

Mindfulness & Stress Management Study for Cardiac Patients

University of Minnesota

NCT02722213

COMPLETED NA 46 participants

RecoverLINK Technology Pilot for HF Patients

RecoverLINK

NCT02815085

COMPLETED 43 participants

Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure

InCardia

NCT04928326

COMPLETED 43 participants

Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery

The University of Texas Health Science Center, Houston

NCT00178633

COMPLETED NA 43 participants

Values-Affirmation + Education Intervention Targeting Medication Adherence in Older Adults With Heart Failure

The Miriam Hospital

NCT05575375

COMPLETED Phase 1 42 participants

Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response

Washington University School of Medicine

NCT02797184

COMPLETED Phase 1 41 participants

Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1

The University of Texas Health Science Center at San Antonio

NCT03560323

COMPLETED NA 38 participants

Sensor-controlled Digital Game for Heart Failure Self-management

University of Texas at Austin

NCT03947983

COMPLETED 37 participants

Implantable Cardioverter Defibrillator (ICD) Function During Ventricular Assist Device (VAD) Implantation

Virginia Commonwealth University

NCT01576562

COMPLETED NA 36 participants

Vitamin C Supplementation Intervention

University of North Carolina, Chapel Hill

NCT04036110

COMPLETED Phase 4 36 participants

Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

NxStage Medical

NCT00288587

COMPLETED NA 35 participants

Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) Study

Zoll Medical Corporation

NCT02825966

COMPLETED NA 33 participants

Heart Failure Resilience Intervention for Caregivers

Johns Hopkins University

NCT03963583

COMPLETED Phase 2 33 participants

Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

University of Pittsburgh

NCT03015402

← Previous Page 7 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 28
Phase 2 35
Phase 3 24
Phase 4 23

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Heart Failure right now

164 recruiting of 399 indexed (41% open).

Phase mix: 47 late (III/IV) vs 63 early (I/II) (balanced across stages).

Top sponsor: Abbott Medical Devices (15 trials), 9 others listed. 50 shown below, recruiting first. #13 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Heart Failure?

PlainTrial tracks 399 US clinical trials for Heart Failure, of which 164 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Heart Failure?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.